$AMPX
Amprius Technologies, Inc.

2022 Q2 Form 10-Q Financial Statement

#000119312522220093 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $691.0K $2.110M $2.772M
YoY Change -36.2% 1375.52%
Cost Of Revenue $2.081M $3.149M $7.101M
YoY Change 11.4% 177.2%
Gross Profit -$1.390M -$1.039M -$4.329M
YoY Change 77.07% 4.63%
Gross Profit Margin -201.16% -49.24% -156.17%
Selling, General & Admin $2.320M $1.502M $4.844M
YoY Change 178.51% 188.29%
% of Gross Profit
Research & Development $451.0K $369.0K $1.450M
YoY Change 47.87% 6.65%
% of Gross Profit
Depreciation & Amortization $390.0K $334.0K $814.0K
YoY Change 25.4% 5.7%
% of Gross Profit
Operating Expenses $2.771M $1.871M $6.294M
YoY Change 143.5% 115.8%
Operating Profit -$1.672M -$114.4K -$10.62M
YoY Change 16448.7% 343.05%
Interest Expense $7.000K $0.00 $0.00
YoY Change 250.0% -100.0%
% of Operating Profit
Other Income/Expense, Net $4.553M -$141.4K -$16.00K
YoY Change -75979.23% 1920.44%
Pretax Income -$4.154M -$2.878M -$9.896M
YoY Change 250.84% 53.99%
Income Tax
% Of Pretax Income
Net Earnings $2.881M -$255.8K -$9.896M
YoY Change -28619.14% 890.76%
Net Earnings / Revenue 416.93% -12.12% -357.0%
Basic Earnings Per Share -$0.06 -$0.04
Diluted Earnings Per Share -$49.35K -$34.19K -$117.6K
COMMON SHARES
Basic Shares Outstanding 65.78M shares 65.77M shares
Diluted Shares Outstanding 65.78M shares 65.77M shares

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.243M $8.616M
YoY Change
Cash & Equivalents $1.966M $2.651M $77.15K
Short-Term Investments
Other Short-Term Assets $1.697M $1.287M
YoY Change
Inventory $329.0K $339.0K $500.0K
Prepaid Expenses $223.4K $350.0K
Receivables $490.0K $471.0K $262.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.190M $3.001M $77.15K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $6.559M $6.866M $4.210M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.478M $89.00K $0.00
YoY Change
Total Long-Term Assets $230.4M $230.0M $307.2K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.190M $3.001M $77.15K
Total Long-Term Assets $230.4M $230.0M $307.2K
Total Assets $232.6M $233.0M $384.4K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.67K $71.14K $63.63K
YoY Change
Accrued Expenses $1.154M $149.1K $155.1K
YoY Change
Deferred Revenue $2.363M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.184M $220.2K $418.7K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.056M $3.068M
YoY Change
Total Long-Term Liabilities $3.056M $3.068M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.184M $220.2K $418.7K
Total Long-Term Liabilities $3.056M $3.068M
Total Liabilities $20.74M $24.07M $418.7K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$18.35M -$21.04M -$59.31K
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$18.35M -$21.04M -$34.31K
YoY Change
Total Liabilities & Shareholders Equity $232.6M $233.0M $384.4K
YoY Change

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income $2.881M -$255.8K -$9.896M
YoY Change -28619.14% 890.76%
Depreciation, Depletion And Amortization $390.0K $334.0K $814.0K
YoY Change 25.4% 5.7%
Cash From Operating Activities -$2.449M -$413.5K -$3.328M
YoY Change 82.08% -87.63%
INVESTING ACTIVITIES
Capital Expenditures -$160.0K -$34.00K -$351.0K
YoY Change -19.19% -43.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$160.0K -$230.0M -$351.0K
YoY Change -19.19% 383233.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -431.0K 233.0M 15.12M
YoY Change -127.23% 6726.47%
NET CHANGE
Cash From Operating Activities -2.449M -413.5K -3.328M
Cash From Investing Activities -160.0K -230.0M -351.0K
Cash From Financing Activities -431.0K 233.0M 15.12M
Net Change In Cash -3.040M 2.574M 11.44M
YoY Change -7700.0% 25638.25%
FREE CASH FLOW
Cash From Operating Activities -$2.449M -$413.5K -$3.328M
Capital Expenditures -$160.0K -$34.00K -$351.0K
Free Cash Flow -$2.289M -$379.5K -$2.977M
YoY Change 99.56% -88.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001899287
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
KENSINGTON CAPITAL ACQUISITION CORP. IV
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity File Number
EntityFileNumber
001-41314
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1591811
dei Entity Address Address Line1
EntityAddressAddressLine1
1400 Old Country Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 301
dei Entity Address City Or Town
EntityAddressCityOrTown
Westbury
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11590
dei City Area Code
CityAreaCode
703
dei Local Phone Number
LocalPhoneNumber
674-6514
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 us-gaap Cash
Cash
1966389
CY2021Q4 us-gaap Cash
Cash
77151
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
223380
CY2022Q2 us-gaap Assets Current
AssetsCurrent
2189769
CY2021Q4 us-gaap Assets Current
AssetsCurrent
77151
CY2022Q2 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
108333
CY2022Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
230294899
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
307243
CY2022Q2 us-gaap Assets
Assets
232593001
CY2021Q4 us-gaap Assets
Assets
384394
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
29673
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
63628
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1154373
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
155077
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
200000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1184046
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
418705
CY2022Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
11310000
CY2022Q2 kcac Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
8050000
CY2022Q2 kcac Working Capital Loan Related Party Noncurrent
WorkingCapitalLoanRelatedPartyNoncurrent
200000
CY2022Q2 us-gaap Liabilities
Liabilities
20744046
CY2021Q4 us-gaap Liabilities
Liabilities
418705
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
230194899
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24014
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18346930
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59311
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-18345944
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-34311
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
232593001
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
384394
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1611750
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10102
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1706154
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35924
CY2022Q2 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
60000
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
80000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1671750
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10102
us-gaap Operating Income Loss
OperatingIncomeLoss
-1786154
us-gaap Operating Income Loss
OperatingIncomeLoss
-35924
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4290000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4680000
CY2022Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
262416
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
294965
CY2022Q2 kcac Offering Costs Associated With Derivative Warrant Liabilities
OfferingCostsAssociatedWithDerivativeWarrantLiabilities
-338
kcac Offering Costs Associated With Derivative Warrant Liabilities
OfferingCostsAssociatedWithDerivativeWarrantLiabilities
563642
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4552754
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4411323
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2881004
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-10102
us-gaap Net Income Loss
NetIncomeLoss
2625169
us-gaap Net Income Loss
NetIncomeLoss
-35924
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-34311
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1440000
CY2022Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
22186565
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-255835
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-21036711
CY2022Q2 kcac Offering Costs Allocated To Class A Ordinary Shares Subject To Possible Redemption
OfferingCostsAllocatedToClassAOrdinarySharesSubjectToPossibleRedemption
4662
CY2022Q2 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
194899
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2881004
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-18345944
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
0
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-25822
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-822
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-10102
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-10924
us-gaap Net Income Loss
NetIncomeLoss
2625169
us-gaap Net Income Loss
NetIncomeLoss
-35924
kcac General And Administrative Expenses Paid By Related Party In Exchange For Issuance Of Class B Ordinary Shares
GeneralAndAdministrativeExpensesPaidByRelatedPartyInExchangeForIssuanceOfClassBOrdinaryShares
25000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4680000
kcac Offering Costs Associated With Derivative Warrant Liabilities
OfferingCostsAssociatedWithDerivativeWarrantLiabilities
563642
kcac Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
294899
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
331713
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16045
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10924
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1124689
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-977067
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
230000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-230000000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
230000000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
8000000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
5133695
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
232866305
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1889238
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77151
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1966389
kcac Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
25000
kcac Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
39266
kcac Deferred Underwriting Compensation
DeferredUnderwritingCompensation
8050000
kcac Remeasurement Of Classa Ordinary Shares Subject To Possible Redemption
RemeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption
194899
kcac Restricted Investments Term
RestrictedInvestmentsTerm
P185D
CY2022Q2 kcac Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination
PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination
1
kcac Lock In Period For Redemption Of Public Shares After Closing Of Ipo
LockInPeriodForRedemptionOfPublicSharesAfterClosingOfIpo
P24M
kcac Dissolution Expense
DissolutionExpense
100000
kcac Minimum Share Price Of The Residual Assets Remaining Available For Distribution
MinimumSharePriceOfTheResidualAssetsRemainingAvailableForDistribution
10
CY2022Q2 us-gaap Cash
Cash
2000000
CY2022Q2 kcac Working Capital Deficit
WorkingCapitalDeficit
1000000
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of June 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div></div>
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
0
CY2022Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
0
kcac Underwriting Discount Paid Per Unit
UnderwritingDiscountPaidPerUnit
0.2
us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
4600000
kcac Deferred Underwriting Commission Per Unit
DeferredUnderwritingCommissionPerUnit
0.35
CY2022Q2 kcac Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
8100000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
3135

Files In Submission

Name View Source Status
0001193125-22-220093-index-headers.html Edgar Link pending
0001193125-22-220093-index.html Edgar Link pending
0001193125-22-220093.txt Edgar Link pending
0001193125-22-220093-xbrl.zip Edgar Link pending
d374804d10q.htm Edgar Link pending
d374804dex311.htm Edgar Link pending
d374804dex312.htm Edgar Link pending
d374804dex321.htm Edgar Link pending
d374804dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kcac-20220630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
kcac-20220630_cal.xml Edgar Link unprocessable
kcac-20220630_pre.xml Edgar Link unprocessable
kcac-20220630_def.xml Edgar Link unprocessable
kcac-20220630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d374804d10q_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending